Array BioPharma, Inc. to Present at Leerink Swann and Company Oncology Roundtable Conference

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Leerink Swann Oncology Roundtable Conference on May 20 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
MORE ON THIS TOPIC